Metabolic compensation and depression in Alzheimer's disease

Dement Geriatr Cogn Disord. 2010;29(1):37-45. doi: 10.1159/000257761. Epub 2010 Jan 27.

Abstract

Background/aims: The aim of this study was to map metabolic compensation and depression in Alzheimer's disease (AD) on a voxel-by-voxel basis.

Methods: Twenty-one healthy elderly subjects and 25 AD patients underwent cerebral MR and FDG-PET imaging. All images were processed with SPM2, and whole-brain gray matter (GM) atrophy and hypometabolism maps were computed. Metabolic compensation and depression were assessed using Biological Parametric Mapping software.

Results: GM atrophy and hypometabolism mapped to similar regions, with varying degrees of severity. Significant metabolic compensation was found in the amygdala, while exceeding hypometabolism was mainly located in the posterior cingulate cortex.

Conclusion: Metabolic depression can be due to both distant effects of atrophy and to additional hypometabolism-inducing factors, such as amyloid deposition. Conversely, metabolic compensation could reflect spared synaptic plasticity of the surviving neurons. The investigation of the metabolic compensation mechanism could help in the comprehension of the AD underlying pathology.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Alzheimer Disease / complications
  • Alzheimer Disease / metabolism*
  • Alzheimer Disease / psychology*
  • Atrophy
  • Brain / pathology
  • Brain Chemistry
  • Depression / etiology
  • Depression / metabolism*
  • Depression / psychology*
  • Executive Function / physiology
  • Female
  • Fluorodeoxyglucose F18
  • Health Status
  • Humans
  • Image Processing, Computer-Assisted
  • Magnetic Resonance Imaging
  • Male
  • Memory / physiology
  • Middle Aged
  • Neuropsychological Tests
  • Positron-Emission Tomography
  • Psychiatric Status Rating Scales
  • Radiopharmaceuticals

Substances

  • Radiopharmaceuticals
  • Fluorodeoxyglucose F18